ArticleBMC cancer2015

Retreatment with anti-EGFR based therapies in metastatic colorectal cancer: impact of intervening time interval and prior anti-EGFR response.

X Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.